Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of DKF-313 vs Avodart + Cialis in Healthy Males
NCT02352311Phase 1Completed
- Sponsor
- Dongkook Pharmaceutical
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dutasteride + tadalafil in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Dongkook Pharmaceutical. Primary endpoints: Area under the concentration-time curve from time zero to the last measurable concentration at 192 hours and Maximum plasma concentration at 192 hours. Started Jan 2015; status: completed.
02
Drugs
dutasteride + tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02352311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02352311.